5th International Andrology Symposium

Bringing together experts from molecular biology, pediatric endocrinology, pediatric surgery, and andrology, the 2025 symposium offered a comprehensive view of current advances in diagnosis, mechanisms, and treatment. Discussions repeatedly emphasized that cryptorchidism must be understood as more than a simple failure of testicular descent. Instead, it represents a condition shaped by endocrine programming, germ-cell biology, molecular architecture, and increasingly recognized, neurocognitive factors.

One particularly striking theme emerging from both the in-person and virtual sessions was the importance of hormonal treatment not only for testicular maturation but also for potential improvements in memory and cognition in cryptorchid boys. These observations broaden the conceptual framework of cryptorchidism beyond an anatomic disorder and reinforce the view that early disturbances of the hypothalamic–pituitary–gonadal axis carry systemic developmental implications.

The central focus of the symposium was the integration of molecular biology with pediatric endocrine practice. Several talks delineated how PIWIL and TUDOR gene families, essential for germline genome protection and piRNA biology, may play decisive roles in shaping fertility potential in boys with undescended testes. These discussions highlighted how translational genetics is reshaping our understanding of the germ-cell consequences of cryptorchidism.

Equally compelling were the contributions examining epigenetic mechanisms and the role of estrogenic signaling in the origin of cryptorchidism. Presentations highlighted how endocrine and epigenetic perturbations during fetal life and mini-puberty can disrupt the transformation of gonocytes and interfere with Sertoli- and Leydig-cell maturation. These findings underscore a broader principle that hormonal and epigenetic disruptions underlie the etiology of many apparently mechanical cases of undescended testes.

Another notable topic was the emerging evidence regarding the cystic fibrosis factor and its involvement in fertility development. The symposium examined how this factor responds negatively to a hypogonadotropic state in cryptorchid boys at high risk for infertility, adding a new dimension to the classification of biological vulnerability and demonstrating the expanding reach of molecular diagnostics.

These molecular, endocrine, and epigenetic insights converged on a significant clinical conclusion: the aberrations identified cannot be corrected by early surgery alone. While timely orchiopexy remains essential for anatomic repositioning and long-term surveillance, it does not address upstream defects arising from mini-puberty disturbances, hormonal insufficiency, or molecular instability. Consequently, the meeting’s interdisciplinary consensus was that hormonal therapy—particularly GnRH agonists or hCG—should be strongly considered as part of treatment guidance, especially for boys exhibiting biological markers of high infertility risk. Incorporating endocrine induction into management pathways was viewed not as experimental, but as a logical evolution of mechanism-based care.

The preparation of these proceedings benefited from OpenAI’s Deep Research tool, used exclusively for copy-editing, proofreading, and improving linguistic clarity and organization. Its application did not generate new scientific or conceptual content; every scientific idea herein remains the original work of the contributing authors. Each manuscript included in this volume has been carefully reviewed for factual accuracy and approved by its author(s) and by the editorial team.

We hope that this collection reflects the depth, rigor, and collaborative spirit of the 2025 meeting. As cryptorchidism continues to be redefined through advances in molecular biology, endocrinology, and developmental science, it is our conviction that meetings such as this—and the shared knowledge they generate—will play a critical role in shaping the next generation of evidence-based, mechanistically informed care for affected boys worldwide.